Epidural Steroids With Intrathecal Nalbuphine for Lower Abdominal Oncologic Surgery

• Status: Completed
• Trial end date: 2018-01-07
• Target enrollment: 0
• Participant gender: All

Summary

Intraoperative pain, nausea, vomiting, hypotension, bradycardia are known side effects during lower abdominal surgery under spinal anesthesia, Time to 2 segment regression of sensory block and duration of effective analgesia prolonged with intrathecal (IT) 0.4 mg nalbuphine & IT 0.8 mg nalbuphine, but the incidence of side-effects was significantly higher with IT 0.8 mg nalbuphine compared with (IT) 0.4 mg nalbuphine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University
• Treatments: BB 1101; Bupivacaine; Dexamethasone; Dexamethasone acetate; Nalbuphine

Criteria

Inclusion Criteria:

• American Society of Anesthesiologists physical class I or II.

• Undergoing laparotomy

• Undergoing oophorectomy

• Undergoing hysterectomy

• Undergoing rectal mass excision

Exclusion Criteria:

• Patient refusal.

• Hypersensitivity to amide local anesthetics.

• General contraindications to spinal anesthesia.

• Cardiac diseases.

• Hepatic failure.

• Renal failure.

• Respiratory failure.

• Communication barriers.